window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 3, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Chronic diseases,Data Management,Drug Development,Pharmaceuticals and therapeutics,Real world evidence,Research & Development

    New Phesi data shows more than 100 diseases being studied with GLP-1 therapies

    Analysis highlights potential for benefits far beyond obesity, signalling a [...]

    September 12, 2025
  • Chronic diseases,Clinical Trials,Pharmaceuticals and therapeutics,Research & Development

    First patient dosed in Resolution Therapeutics’ Emerald study of RTX001 for cirrhosis

    Resolution Therapeutics, a clinical-stage biopharmaceutical company developing regenerative macrophage therapy [...]

    September 9, 2025
  • Genomics and sequencing,Global health,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    Kling Bio and Sanofi join forces to speed discovery of neutralizing antibodies

    Kling Bio has announced a collaboration and license option agreement [...]

    September 9, 2025
  • Drug Development,Oncology,Partnerships & Funding,Precision medicine,Research & Development

    New glioblastoma treatment project secures funding from The Brain Tumour Charity

    Medicines Discovery Catapult (MDC) and King’s College London (KCL) have [...]

    September 9, 2025
  • Cell & Gene Therapy,Neurosciences,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    TRIMTECH Therapeutics establishes scientific advisory board to advance targeted protein degradation

    TRIMTECH Therapeutics, a biotech developing small molecule therapeutics that selectively [...]

    September 9, 2025
  • Clinical Development,Neurosciences,Partnerships & Funding,Pharmaceuticals and therapeutics,Rare Diseases,Research & Development

    NRG Therapeutics closes oversubscribed £50m series B to advance clinical data in Parkinson’s and proof of concept in ALS/MND

    NRG Therapeutics Ltd, a neuroscience company developing treatments targeting mitochondrial [...]

    September 8, 2025
  • Artificial Intelligence,Biotech,Clinical Development,Data Management,Drug Development,Research & Development

    Biostate AI launches K-Dense beta to accelerate biological discovery from years to days

    Biostate AI has launched K-Dense Beta, a multi-agent AI system [...]

    September 22, 2025
  • Genomics and sequencing,Research & Development,Technology and platforms

    Bio-Rad expands range of StarBright dyes to enhance panel design capabilities for spectral flow cytometry

    Bio-Rad Laboratories, a global provider of life science research and [...]

    August 27, 2025
  • Biologics & Biosimilars,Drug Development,Global health,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Cerium catalyst breakthrough could streamline greener drug development

    Japanese researchers discover a way to perform two different chemical [...]

    August 21, 2025
  • Chronic diseases,Genomics and sequencing,Precision medicine,Research & Development

    Genomics and sequencing: Sapient study uses rLC-MS to map metabolic aging and disease insights in 26,000 samples

    Sapient has published a large-scale metabolomics study using its rapid [...]

    August 20, 2025
Previous202122Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Ribbon CEO calls for faster adoption of AI and DNA synthesis to accelerate drug development
    Categories: Biotech, Digital Health, Research & Development
  • FDA signals continued access for desiccated thyroid extract products as manufacturers move toward biologics pathway
    Categories: Regulatory Affairs, Research & Development
  • Tozorakimab meets primary endpoint in two Phase 3 COPD trials, showing reduction in exacerbations
    Categories: Clinical Trials, Research & Development, Respiratory
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top